Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Nausea and Vomiting, Prophylaxis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02519842
What this trial is testing

Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondansetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Merck Sharp & Dohme LLC 75
Testing effectiveness (Phase 2)Study completedNCT04508400
What this trial is testing

Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients

Who this might be right for
Pediatric Cancer
Sun Yat-sen University 108
Testing effectiveness (Phase 2)Study completedNCT01054456
What this trial is testing

Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)

Who this might be right for
Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC
Eisai Inc. 36
Post-approval studies (Phase 4)Study completedNCT04585412
What this trial is testing

Evaluate Bioequivalence of Palonosetron (0.25mg/5mL)

Who this might be right for
Chemotherapy-induced Nausea and Vomiting, Prophylaxis
Yung Shin Pharm. Ind. Co., Ltd. 16
Large-scale testing (Phase 3)Looking for participantsNCT06850454
What this trial is testing

Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy

Who this might be right for
Chemotherapy Induced Nausea and Vomiting
Mahidol University 140
Testing effectiveness (Phase 2)Looking for participantsNCT07726433
What this trial is testing

Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINV

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Tianjin Medical University Cancer Institute and Hospital 56
Post-approval studies (Phase 4)UnknownNCT03571126
What this trial is testing

Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer

Who this might be right for
Chemotherapy-induced Nausea and VomitingLung Cancer
Zunyi Medical College 156
Testing effectiveness (Phase 2)Study completedNCT00503386
What this trial is testing

Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting

Who this might be right for
NauseaVomitingChemotherapy
Hangzhou Jiuyuan Gene Engineering Co. Ltd., 144
Not applicableStudy completedNCT01093690
What this trial is testing

Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin

Who this might be right for
Cancer
Mahidol University 162
Large-scale testing (Phase 3)Ended earlyNCT04503668
What this trial is testing

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Who this might be right for
Gynecologic Cancer
University of Michigan Rogel Cancer Center 62
Testing effectiveness (Phase 2)UnknownNCT04472143
What this trial is testing

Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents

Who this might be right for
Chemotherapy-induced Nausea and Vomiting (CINV)
Fudan University 60
Large-scale testing (Phase 3)UnknownNCT00571168
What this trial is testing

Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-dose Chemotherapy

Who this might be right for
Multiple Myeloma
Heidelberg University 362
Testing effectiveness (Phase 2)Study completedNCT00212602
What this trial is testing

ONO-7436 Phase II Study in Japan

Who this might be right for
Malignant Tumor
Ono Pharmaceutical Co., Ltd. 420
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06593782
What this trial is testing

Evaluating the Efficacy and Safety of HSK21542 Injection in Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Nausea and Vomiting, Chemotherapy-Induced
First Affiliated Hospital of Wenzhou Medical University 180
Large-scale testing (Phase 3)UnknownNCT02933099
What this trial is testing

Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 300
Large-scale testing (Phase 3)Study completedNCT01594749
What this trial is testing

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting (CINV)
Merck Sharp & Dohme LLC 1,015
Testing effectiveness (Phase 2)Study completedNCT02390648
What this trial is testing

Efficacy of Ginger as an Adjunctive Prophylaxis for Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Mahidol University 34
Not applicableWithdrawnNCT03996863
What this trial is testing

Prevention of Unmitigated Chemotherapy-induced Emesis

Who this might be right for
Chemotherapy-induced Nausea and VomitingNausea Post Chemotherapy
Otolith Labs
Post-approval studies (Phase 4)Looking for participantsNCT04150614
What this trial is testing

BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

Who this might be right for
Nausea With Vomiting Chemotherapy-Induced
University of Illinois at Chicago 90
Testing effectiveness (Phase 2)UnknownNCT01581918
What this trial is testing

Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Faculdade de Medicina do ABC 43
Next Page